Up-regulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity
Biochemical Journal · 20.12.2023 · 480 (24) · 2045-2058
DOI: 10.1042/bcj20230317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Journal, online erschienen am 18.12.2023. Verfasst von Shawn Lu Wen Tan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore 138673, R…. Hauptthemen laut MEDLINE: Cystine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: MOH | National Medical Research Council, A*STAR | Institute of Molecular and Cell Biology, National Research Foundation Singapore.
Abstract (Originalsprache)
The SLC7A11/xCT cystine and glutamate antiporter has emerged as an attractive target for cancer therapy due to its selective overexpression in multiple cancers and its role in preventing ferroptosis. Utilizing pharmacological and genetic approaches in hepatocellular carcinoma cell lines, we demonstrate that overexpression of SLC7A11 engenders hypersensitivity towards l-selenocystine, a naturally occurring diselenide that bears close structural similarity to l-cystine. We find that the abundance of SLC7A11 positively correlates with sensitivity to l-selenocystine, but surprisingly, not to Erastin, an inhibitor of SLC7A11 activity. Our data indicate that SLC7A11 acts as a transport channel for l-selenocystine, which preferentially incites acute oxidative stress and damage eventuating to cell death in cells that highly express SLC7A11. Hence, our findings raise the prospect of l-selenocystine administration as a novel strategy for targeting cancers that up-regulate SLC7A11 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Republic of Singapore.
- Institute of Biochemistry, Food Science and Nutrition, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel.
- NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, 14 Medical Drive, Singapore 117599, Republic of Singapore.
- Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 8 Medical Drive, Singapore 117597, Republic of Singapore.
- Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), 60 Biopolis Drive, Genome, Singapore 138672, Republic of Singapore.
- Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore 117599, Republic of Singapore.
ORCID-Profile: Shawn Lu Wen Tan
Förderung
- MOH | National Medical Research Council
- A*STAR | Institute of Molecular and Cell Biology
- National Research Foundation Singapore
Zitieren
APA
Tan, S. L. W., Tan, H. M., Israeli, E., Fatihah, I., Ramachandran, V., Ali, S. B., Goh, S. J. A., Wee, J., Tan, A. Q. L., Tam, W. L., & Han, W. (2023). Up-regulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity. Biochemical Journal, 480(24), 2045-2058. https://doi.org/10.1042/bcj20230317
Vancouver
Tan SLW, Tan HM, Israeli E, Fatihah I, Ramachandran V, Ali SB, et al. Up-regulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity. Biochemical Journal. 2023;480(24):2045-2058. doi:10.1042/bcj20230317
BibTeX
@article{Tan2023,
author = {Tan, Shawn Lu Wen and Tan, Hui Min and Israeli, Erez and Fatihah, Indah and Ramachandran, Vignesh and Ali, Shamsia Bte and Goh, Shane Jun An and Wee, Jillian and Tan, Alicia Qian Ler and Tam, Wai Leong and Han, Weiping},
title = {Up-regulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity},
journal = {Biochemical Journal},
year = {2023},
volume = {480},
number = {24},
pages = {2045--2058},
doi = {10.1042/bcj20230317}
}
EUVIMED